AMSTERDAM, the Netherlands—It’s no surprise that injectable semaglutide leads to significant weight loss among obese heart failure patients with preserved ejection fraction (HFpEF), but as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results